News

CVS Health will not cover Gilead's Yeztugo, generic name lenacapavir (LEN), citing "clinical, financial, and regulatory ...
Chief Judge Mitchell Goldberg tripled to $285 million the damages he had ordered CVS Caremark to pay in June, citing the ...
Whistleblower Sarah Behnke's lawsuit leads to a $290 million judgment against CVS Caremark for overcharging Medicare on ...
CVS Health (CVS) stock in focus as its pharmacy benefit manager CVS Caremark faces $289.9M in damages and penalties for ...
CVS Health (NYSE:CVS), one of the leading health insurers in the U.S. and owner of the Pharmacy Benefit Manager Caremark, ...
We recently published 12 Latest Stocks On Jim Cramer’s Radar. CVS Health Corporation (NYSE:CVS) is one of the stocks Jim ...
Heading into the respiratory illness season, states and clinicians are working to encourage pregnant patients to get COVID-19 ...
Tools like Claimable and Fight Health Insurance use AI to guide people through the insurance appeals process and generate ...
CVS Health , which runs the largest U.S. pharmacy benefit manager, will not add Gilead Sciences' new HIV prevention drug to ...
Through the power of strategic, well-built partnerships, CVS Health helps employees earn degrees — and at no cost to them.
The owner of the United States' largest pharmacy benefit manager (PBM) is declining to cover Gilead Sciences’ long-acting HIV ...
Fintel reports that on August 18, 2025, UBS upgraded their outlook for CVS Health (NYSE:CVS) from Neutral to Buy. Analyst ...